Bulk Pharmaceutical API Sources for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER

Bulk Pharmaceutical API Sources for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		M4659_SIGMA
Calbiochem		475840
NIH Clinical Collection		SAM001246611
NovoSeek		4197
IS Chemical Technology		I06-0259
MP Biomedicals		158962
TCI (Tokyo Chemical Industry)		M1663

Bulk Active Pharmaceutical Ingredient (API) Sources for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER

Last updated: July 27, 2025

---

Introduction

Primacor (methylenedioxymethamphetamine) is frequently referenced in pharmacological contexts under different nomenclatures, but within the scope of dextrose solutions, the focus often zeros in on the source and quality of Active Pharmaceutical Ingredient (API)—specifically, dextrose (glucose). The 5% dextrose in plastic containers used in clinical settings hinges on sourcing high-quality APIs that meet stringent pharmacopoeial standards, ensuring safety, efficacy, and regulatory compliance. This article explores key sources and considerations for bulk dextrose API suitable for manufacturing Primacor 5% dextrose solutions in plastic containers.

---

Regulatory and Quality Standards for API Sourcing

Before delving into sources, it's critical to underline the importance of sourcing APIs that conform to internationally recognized pharmacopeias like USP, EP, or JP. These standards ensure API purity, potency, and safety for infusion solutions. Importers and manufacturers must verify documentation inclusively covering Certificates of Analysis (CoA), Good Manufacturing Practice (GMP) compliance, and traceability.

---

Primary API Suppliers for Dextrose in Pharmaceutical Applications

1. U.S. and European Pharmacopoeial Suppliers

• Cargill, Inc.
  As a leading global supplier, Cargill produces high-quality dextrose monohydrate and dextrose anhydrous conforming to USP and EP specifications. Their products are used extensively in injectable and infusible solutions and have GMP certifications crucial for pharmaceutical manufacturing [1].

• Roquette Frères
  A European-based manufacturer with a strong reputation in nutritional and pharmaceutical ingredient markets, Roquette supplies pharmaceutical-grade glucose (dextrose) complying with USP, EP, and other specifications. They have dedicated facilities for parenteral-grade ingredients, emphasizing purity and safety [2].

• Cargill-Albion
  Specializes in pharmaceutical excipients and ingredients, offering dextrose API with strict compliance to pharmacopoeias, supporting use in hospital and commercial infusion solutions.

2. Asian API Manufacturers

• Shandong Xinchangyuan Bio-Tech Co., Ltd. (China)
  This supplier produces pharmaceutical-grade glucose API with compliance to USP and EP standards, established through rigorous quality management systems [3].

• Changzhou Kangwen bio-tech Co., Ltd. (China)
  Provides GMP-grade dextrose API suitable for injectable products, with certification demonstrating adherence to pharmacopeial standards [4].

3. Global Contract Manufacturing Organizations (CMOs)

• Fresenius Kabi
  As a major provider of infusion solutions, Fresenius Kabi sources dextrose API from qualified manufacturers, ensuring adherence to pharmacopoeial norms and GMP clearance.

• Baxter International
  Engages with multiple API suppliers to maintain supply chain integrity for dextrose used in parenteral formulations.

---

Criteria for Selecting API Suppliers

When sourcing dextrose API for Primacor 5% Dextrose solutions in plastic containers, consider:

• Regulatory Compliance: Ensure the API is certified compliant with USP, EP, or other relevant pharmacopoeias.
• GMP Certification: Integral for manufacturing injectable solutions, GMP reduces risks associated with contamination.
• Traceability: Maintain detailed documentation including batch records, CoA, and testing reports.
• Purity and Specification: Confirm the API's specifications for purity (typically >99%), residual moisture, particle size, and absence of contaminants.
• Supply Stability: Opt for suppliers with reliable production capacity and consistent supply chains to meet manufacturing demands.

---

Quality Control and Certification

APIs used in formulations like Primacor 5% dextrose solutions must undergo comprehensive quality analysis:

• Microbial Testing: Ensuring absence of microbial contamination.
• Chemical Testing: Confirming chemical purity and absence of impurities.
• Moisture Content: Critical for stability and compatibility in infusion solutions.
• Endotoxin Levels: Especially relevant for injectables to prevent pyrogenic reactions.

Manufacturers must verify these parameters through rigorous testing in accredited laboratories before integration into production processes.

---

Supply Chain Considerations

The sourcing process involves a strategic evaluation of:

• Geographical Risks: Global events impacting specific regions (e.g., trade restrictions, pandemics) can influence APIs supply.
• Cost and Lead Time: Balancing quality requirements with logistical and financial factors.
• Supplier Audits: Performing due diligence and auditing supplier facilities to confirm GMP adherence.

---

Future Trends in API Sourcing

Advances in manufacturing technology and regulatory incentives encourage more manufacturers toward microbial-free and sustainable API production. Additionally, increased adoption of biosynthetic or bioengineered dextrose may influence supply dynamics, offering avenues for higher purity and consistency.

---

Conclusion

Ensuring a reliable, high-quality source of dextrose API is fundamental for the consistent production of Primacor 5% dextrose solutions in plastic containers. Leading global suppliers such as Cargill and Roquette dominate the market, supported by rigorous quality standards and certifications. As regulatory landscapes evolve, manufacturers must prioritize audited, compliant sources that guarantee safety, efficacy, and supply chain integrity.

---

Key Takeaways

• Certification & Compliance: Always select API suppliers with validated GMP practices and pharmacopoeial certification to meet pharmaceutical standards.
• Supplier Due Diligence: Conduct comprehensive audits and verify documentation to mitigate risks of contamination or substandard quality.
• Supply Chain Stability: Maintain diversified supplier relationships to prevent disruptions in critical infusion solution manufacturing.
• Quality Control: Implement rigorous testing protocols for purity, endotoxin, residual moisture, and microbial content.
• Future Readiness: Stay abreast of technological advances and regulatory shifts affecting API production and sourcing strategies.

---

FAQs

1. What are the key regulatory standards for sourcing dextrose API?
The primary standards are the USP, EP, and JP pharmacopeias. These specifications ensure API safety, purity, and suitable characteristics for infusion solutions.

2. How do I verify the quality of API suppliers?
Request Certificates of Analysis, GMP compliance documentation, and audit reports. Confirm that laboratory testing aligns with pharmacopeial standards.

3. Can synthetic or bioengineered dextrose be used in Primacor formulations?
Yes, provided the product meets pharmacopeial specifications, is GMP-certified, and passes all safety and purity testing appropriate for parenteral use.

4. Are there regional differences in API quality standards?
While global standards like USP and EP are widely recognized, regional regulations may require additional certifications or testing. It's essential to align sourcing with the regulatory jurisdiction in which the product will be marketed.

5. What trends are influencing API sourcing strategies?
Increased focus on supply chain security, sustainability, and technological advancements in biofermentation are shaping future API sourcing approaches, emphasizing quality, reliability, and environmental considerations.

---

References

[1] Cargill. (2023). Pharmaceutical-grade Dextrose Monohydrate.
[2] Roquette. (2023). Pharmaceutical Dextrose Solutions.
[3] Shandong Xinchangyuan Bio-Tech Co., Ltd. Regulatory Certificate.
[4] Changzhou Kangwen Bio-tech Co., Ltd. Certification Documentation.